Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Interest Expenses (2020 - 2021)

Historic Interest Expenses for Foghorn Therapeutics (FHTX) over the last 2 years, with Q4 2021 value amounting to $426000.0.

  • Foghorn Therapeutics' Interest Expenses rose 3271.03% to $426000.0 in Q4 2021 from the same period last year, while for Sep 2022 it was $426000.0, marking a year-over-year decrease of 7634.65%. This contributed to the annual value of $1.9 million for FY2021, which is 9468.85% up from last year.
  • As of Q4 2021, Foghorn Therapeutics' Interest Expenses stood at $426000.0, which was up 3271.03% from $499000.0 recorded in Q3 2021.
  • Over the past 5 years, Foghorn Therapeutics' Interest Expenses peaked at $499000.0 during Q3 2021, and registered a low of $198000.0 during Q2 2020.